scispace - formally typeset
C

Caroline E. Ford

Researcher at University of New South Wales

Publications -  66
Citations -  1933

Caroline E. Ford is an academic researcher from University of New South Wales. The author has contributed to research in topics: Cancer & Wnt signaling pathway. The author has an hindex of 23, co-authored 54 publications receiving 1583 citations. Previous affiliations of Caroline E. Ford include University of Toronto & Malmö University.

Papers
More filters
Journal ArticleDOI

Sensing extracellular matrix: an update on discoidin domain receptor function.

TL;DR: It is shown that the structural organization of these DDR-related genes is highly conserved throughout evolution suggesting that invertebrate DDRs may also function as receptors for collagen, and could help attract new research on DDRs from a variety of different fields.
Journal ArticleDOI

Expression and mutation analysis of the discoidin domain receptors 1 and 2 in non-small cell lung carcinoma.

TL;DR: It is concluded that whereas altered expression of DDRs may contribute to malignant progression of NSCLC, it is unlikely that this results from mutations in the DDR1 and DDR2 genes that were investigated.
Journal Article

Mouse mammary tumor virus-like gene sequences in breast tumors of Australian and Vietnamese women.

TL;DR: MMTV-like gene sequences are found in only some human populations and are rarely found in normal human breast tissue from all populations, suggesting they are not present in the normal human genome and have been acquired.
Journal ArticleDOI

The Wnt signalling pathway is upregulated in an in vitro model of acquired tamoxifen resistant breast cancer

TL;DR: The role of the Wnt signalling pathway in acquired resistance to Tamoxifen is supported and combinatorial treatment with endocrine agents and Wnt pathway inhibitors may be a useful therapeutic option in the future for a subset of breast cancer patients.
Journal ArticleDOI

The Wnt Gatekeeper SFRP4 Modulates EMT, Cell Migration and Downstream Wnt Signalling in Serous Ovarian Cancer Cells

TL;DR: Results indicate that modulation of a single upstream gatekeeper of Wnt signalling can have effects on downstream WNT signalling and ovarian cancer cell behaviour, as mediated through epithelial to mesenchymal plasticity (EMP) and the possibility that SFRP4 may be used both diagnostically and therapeutically in epithelial ovarian cancer.